Lakefront Biotherapeutics (LKFT) Tax Provisions (2014 - 2026)
Lakefront Biotherapeutics (LKFT) posted quarterly Tax Provisions of -$81952.2 for Q1 2026, down 104.29% year-over-year from $1.9 million in Q1 2025, and up 99.81% quarter-over-quarter from -$44.1 million in Q4 2025.
Lakefront Biotherapeutics (LKFT) Tax Provisions (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Tax Provisions for 11 consecutive years, with -$81952.2 the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions fell 104.29% year-over-year to -$81952.2; the TTM figure through Mar 2026 stood at -$23.7 million (down 871.9% YoY), while the FY2025 annual figure was -$21.7 million, down 1025.03% from the prior year.
- Tax Provisions advanced to -$81952.2 in Q1 2026 per LKFT's latest filing, from -$44.1 million in the prior quarter.
- Across five years, Tax Provisions topped out at $23.2 million in Q3 2025 and bottomed at -$44.1 million in Q4 2025.
- Historically, Tax Provisions has averaged -$2.1 million across 5 years, with a median of -$106859.5 in 2024.
- On a YoY basis, Tax Provisions climbed as much as 1066.89% in 2025 and fell as far as 41193.98% in 2025.
- Lakefront Biotherapeutics' Tax Provisions stood at $3.9 million in 2022, then plunged by 158.26% to -$2.3 million in 2023, then surged by 95.27% to -$106859.5 in 2024, then plunged by 41193.98% to -$44.1 million in 2025, then soared by 99.81% to -$81952.2 in 2026.
- Business Quant data shows LKFT's Tax Provisions at -$81952.2 in Q1 2026, -$44.1 million in Q4 2025, and $23.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Lakefront Biotherapeutics | 1.81 Bn | -1.68 Bn | 1.97 Mn | -81,952.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -81,952.20 |
| Dec 31, 2025 | -44.13 Mn |
| Sep 30, 2025 | 23.17 Mn |
| Jun 30, 2025 | -2.66 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | -106,859.54 |
| Sep 30, 2024 | 1.99 Mn |
| Jun 30, 2024 | -717,207.13 |
| Mar 31, 2024 | 617,053.48 |
| Dec 31, 2023 | -2.26 Mn |
| Sep 30, 2023 | 590,016.04 |
| Jun 30, 2023 | -14.03 Mn |
| Mar 31, 2023 | 198,568.24 |
| Dec 31, 2022 | 3.88 Mn |
| Sep 30, 2022 | -735,031.99 |
| Jun 30, 2022 | -828,035.99 |
| Mar 31, 2022 | -1.93 Mn |
| Dec 31, 2021 | 1.25 Mn |
| Sep 30, 2021 | 353,786.20 |
| Jun 30, 2021 | -758,691.01 |